Metformin hydrochloride
Metformin hydrochloride Biofarm contains metformin, a medicine used to treat diabetes. It belongs to a group of medicines called biguanides.
Insulin is a hormone produced by the pancreas that allows the body to take glucose (sugar) from the blood. The body uses glucose to produce energy or stores it for later use.
In diabetic patients, the pancreas does not produce enough insulin or the body is unable to use the produced insulin properly. This leads to an excessive increase in blood glucose levels. Metformin hydrochloride Biofarm helps reduce blood glucose levels to values as close to normal as possible.
In adults with overweight, long-term use of Metformin hydrochloride Biofarm also reduces the risk of complications associated with diabetes. Taking Metformin hydrochloride Biofarm is associated with maintaining or moderately reducing body weight.
Metformin hydrochloride Biofarm is used to treat patients with type 2 diabetes (also called "non-insulin-dependent" diabetes), in whom diet and physical exercise alone cannot achieve sufficient blood glucose control. It is particularly used in patients with overweight.
Adults can take Metformin hydrochloride Biofarm as the only medicine or in combination with other anti-diabetic medicines (oral medicines or insulin).
Children from 10 years of age and adolescents can take Metformin hydrochloride Biofarm as the only medicine or in combination with insulin.
When not to take Metformin hydrochloride Biofarm:
If any of the above situations occur, the patient should consult their doctor before taking this medicine.
It is necessary to consult a doctor if it is necessary to:
Metformin hydrochloride Biofarm must be discontinued for a certain period before and after the examination or surgical procedure. The doctor will decide whether other treatment is necessary during this time. It is essential to follow the doctor's instructions carefully.
Metformin hydrochloride Biofarm may cause a very rare but very serious side effect called lactic acidosis, especially if the patient has kidney dysfunction.
The risk of lactic acidosis increases in case of uncontrolled diabetes, severe infection, prolonged fasting or alcohol consumption, dehydration (see more detailed information below), liver dysfunction, and any conditions in which a part of the body is not sufficiently supplied with oxygen (e.g. acute severe heart disease).
If any of the above circumstances apply to the patient, they should consult their doctor for more detailed instructions.
a condition that may be associated with dehydration(significant water loss from the body), such as severe vomiting, diarrhea, fever, exposure to high temperatures, or if the patient drinks less fluid than usual. The patient should consult their doctor for more detailed instructions.
symptoms of lactic acidosis, as this condition can lead to coma.
Symptoms of lactic acidosis include:
If the patient is to undergo a major surgical procedure, they must not take Metformin hydrochloride Biofarm during the procedure and for a certain period after it. The doctor will decide when the patient should stop and resume treatment with Metformin hydrochloride Biofarm.
Metformin hydrochloride Biofarm does not cause hypoglycemia (low blood sugar). However, if Metformin hydrochloride Biofarm is taken in combination with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylureas, insulin, meglitinides), there is a risk of hypoglycemia. If symptoms of hypoglycemia occur, such as weakness, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating, eating or drinking a sugary drink usually helps.
During treatment with Metformin hydrochloride Biofarm, the doctor will monitor the patient's kidney function at least once a year or more often if the patient is elderly and (or) has impaired kidney function.
If the patient is to be injected with a contrast agent containing iodine into the bloodstream, for example, for an X-ray examination or computed tomography, they must stop taking Metformin hydrochloride Biofarm before or at the latest at the time of such injection. The doctor will decide when the patient should stop and resume treatment with Metformin hydrochloride Biofarm.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. The patient may need more frequent blood glucose checks and kidney function assessments or dose adjustments of Metformin hydrochloride Biofarm by the doctor. It is particularly important to inform about the following medicines:
The patient should avoid consuming excessive amounts of alcohol while taking Metformin hydrochloride Biofarm, as this may increase the risk of lactic acidosis (see "Warnings and precautions").
If the patient is pregnant, thinks they may be pregnant, or plans to have a child, they should consult their doctor, as changes in treatment or blood glucose monitoring may be necessary.
This medicine is not recommended for breastfeeding women or those planning to breastfeed.
Metformin hydrochloride Biofarm does not cause hypoglycemia (low blood sugar). This means that it does not affect the patient's ability to drive or use machines.
However, the patient should be careful if they take Metformin hydrochloride Biofarm in combination with other anti-diabetic medicines that can cause hypoglycemia (such as sulfonylureas, insulin, meglitinides). Symptoms of hypoglycemia include: weakness, dizziness, increased sweating, rapid heartbeat, vision disturbances, or difficulty concentrating. If such symptoms occur, the patient should not drive or use machines.
This medicine should always be taken according to the doctor's instructions. If the patient has any doubts, they should consult their doctor or pharmacist.
Metformin hydrochloride Biofarm does not replace the benefits of a healthy lifestyle. The patient should continue to follow all the doctor's recommendations regarding diet and regular physical activity.
Children from 10 years of age and adolescents: usually start treatment with a dose of 500 mg or 850 mg of Metformin hydrochloride Biofarm once a day. The maximum daily dose is 2000 mg and is taken in 2 or 3 divided doses. Treatment of children from 10 to 12 years of age is only used in case of special recommendation by the doctor, as experience with Metformin hydrochloride Biofarm in this age group is limited.
Adults: usually start treatment with a dose of 500 mg or 850 mg of Metformin hydrochloride Biofarm twice or three times a day. The maximum daily dose is 3000 mg and is taken in 3 divided doses.
If the patient has impaired kidney function, the doctor may prescribe a lower dose.
If the patient is also taking insulin, the doctor will inform them how to start taking Metformin hydrochloride Biofarm.
Metformin hydrochloride Biofarm should be taken during a meal or immediately after a meal.
This will help avoid gastrointestinal side effects.
The tablets should not be crushed or chewed. Swallow the tablet with a glass of water.
If after some time the patient feels that the effect of Metformin hydrochloride Biofarm is too strong or too weak, they should consult their doctor or pharmacist.
If a higher dose of Metformin hydrochloride Biofarm is taken than recommended, lactic acidosis may occur. Symptoms of lactic acidosis are non-specific and include:
vomiting, abdominal pain (abdominal cramps), general feeling of being unwell, accompanied by severe fatigue, and breathing difficulties. Other symptoms include decreased body temperature and slowed heart rate. If any of these symptoms occur, the patient should immediately seek medical attention, as lactic acidosis can lead to coma. The patient should stop taking Metformin hydrochloride Biofarm and contact their doctor or the nearest hospital immediately.
The patient should not take a double dose to make up for a missed dose. They should take the next dose at the usual time.
If the patient has any further doubts about taking this medicine, they should consult their doctor or pharmacist.
Like all medicines, Metformin hydrochloride Biofarm can cause side effects, although not everybody gets them.
The side effects that may occur are presented below.
Metformin hydrochloride Biofarm may very rarely cause (may occur in up to 1 in 10,000 patients) a very serious side effect called lactic acidosis (see "Warnings and precautions"). If this occurs in the patient, they should stop taking Metformin hydrochloride Biofarm and immediately contact their doctor or the nearest hospital, as lactic acidosis can lead to coma.
and other health problems.
Limited data in children and adolescents indicate that the side effects that occur in them are similar in nature and severity to the side effects observed in adults.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
tel.: +48 22 49 21 301, fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children. If Metformin hydrochloride Biofarm is used in a child, it is recommended that the treatment be supervised by parents or caregivers.
There are no special recommendations for storing the medicine.
Do not use this medicine after the expiry date stated on the carton and blister after the expiry date (EXP). The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
One film-coated tablet of Metformin hydrochloride Biofarm, 500 mg contains 500 mg of metformin hydrochloride, which corresponds to 390 mg of metformin.
Film-coated tablet.
Metformin hydrochloride Biofarm, 500 mg
Metformin hydrochloride Biofarm, 500 mg are white to yellowish, biconvex, round film-coated tablets with the inscription MA on one side.
Metformin hydrochloride Biofarm, 500 mg is available in packs containing 20, 30, 50 or 60 tablets.
Not all pack sizes may be marketed.
Biofarm Sp. z o.o.
ul. Wałbrzyska 13
60-198 Poznań
Tel. +48 61 66 51 500
e-mail: biofarm@biofarm.pl
SAG Manufacturing S.L.U
Crta. N-I, Km 36,
San Agustín de Guadalix,
28750 Madrid
Spain
Galenicum Health, S.L.U.
Sant Gabriel, 50,
Esplugues de Llobregat, 08950
08950 Barcelona
Spain
Poland: Metformin hydrochloride Biofarm
Spain: Metformina Biofarm 850 mg comprimidos recubiertos con película EFG
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.